G13 is an essential mediator of platelet activation in hemostasis and thrombosis

Nature Medicine

Volumn 9, Issue 11, 2003, Pages 1418-1422

  Moers, Alexandra ^a   Nieswandt, Bernhard ^b   Massberg, Steffen ^c   Wettschureck, Nina ^a   Grüner, Sabine ^b   Konrad, Ildiko ^c   Schulte, Valerie ^b   Aktas, Barsom ^b   Gratacap, Marie Pierre ^a,e   Simon, Melvin I ^d   Gawaz, Meinrad ^c   Offermanns, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^e CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GUANINE NUCLEOTIDE BINDING ALPHA 12 PROTEIN; GUANINE NUCLEOTIDE BINDING ALPHA 13 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; HEMOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN INDUCTION; PROTEIN TARGETING; REDUCTION; SHEAR STRESS; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE; THROMBOSIS;

ANIMALIA;

EID: 0345708272     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm943     Document Type: Article

References (28)

1. Ruggeri, Z.M. Platelets in atherothrombosis. Nat. Med. 8, 1227-1234 (2002).
2. Bhatt, D.L. & Topol, E.J Scientific and therapeutic advances in antiplatelet therapy. Nat. Rev. Drug Discov. 2, 15-28 (2003).
3. Abrams, C.S. & Brass, L.F. Platelet signal transduction. in Hemostasis and Thrombosis (eds. Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W. & George, J.N.) 541-559 (Lippincott William & Wilkins, Philadelphia, 2001).
4. q deficient mice. Nature 389, 183-186 (1997).
5. Jin, J. & Kunapuli, S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. USA 95, 8070-8074 (1998).
6. i family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J. Biol. Chem. 277, 46035-46042 (2002).
7. 13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J. Cell Biol. 144, 745-754 (1999).
8. 2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA 91, 504-508 (1994).
9. Manganello, J.M., Djellas, Y., Borg, C., Antonakis, K. & Le Breton, G.C. Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13). J. Biol. Chem. 274, 28003-28010 (1999).
10. 13 deficiency. Science 275, 533-536 (1997).
11. q signaling pathways. Proc. Natl. Acad. Sci. USA 99, 9352-9357 (2002)
12. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860-5865 (1996).
13. Kühn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
14. 13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. J. Biol. Chem. 277, 39493-39498 (2002).
15. Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W. & Coughlin, S.R. Role of thrombin signaling in platelets in hemostasis and thrombosis. Nature 413, 74-82 (2001).
16. Savage, B., Cattaneo, M. & Ruggeri, Z.M. Mechanisms of platelet aggregation. Curr. Opin. Hematol. 8, 270-276 (2001).
17. Sah, V.P., Seasholtz, T.M., Sagi, S.A. & Brown, J.H. The role of Rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharmacol. Toxicol. 40, 459-489 (2000).
18. Paul, B.Z., Daniel, J.L. & Kunapuli, S.P. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change. J. Biol. Chem. 274, 28293-28300 (1999).
19. Bauer, M. et al. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets. Blood 94, 1665-1672 (1999).
20. Missy, K. et al. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide. Thromb. Haemost. 85, 514-520 (2001).
21. Schoenwaelder, S.M. et al. RhoA sustains integrin alpha IIbbeta 3 adhesion contacts under high shear. J. Biol. Chem. 277, 14738-14746 (2002).
22. Jantzen, H.M., Milstone, D.S., Gousset, L., Conley, P.B. & Mortensen, R.M. Impaired activation of murine platelets lacking G alpha(i2). J. Clin. Invest. 108, 477-483 (2001).
23. Yang, J. et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc. Natl. Acad. Sci. USA 97, 9984-9989 (2000).
24. Dorsam, R.T., Kim, S., Jin, J. & Kunapuli, S.P. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. J. Biol. Chem. 277, 47588-47595 (2002).
25. 13 proteins in the murine nervous system. Eur. J. Neurosci. 16, 2333-2341 (2002).
26. Ren, X.D. & Schwartz, M.A. Determination of GTP loading on Rho. Methods Enzymol. 325, 264-272 (2000).
27. Kuijpers, M.J. et al. Complementary roles of platelet glycoprotein VI and integrin alpha2beta1 in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J. 17, 685-687 (2003).
28. Massberg, S. et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197, 41-49 (2003).